The Institute of Human Virology Nigeria (IHVN), through its International Research Centre of Excellence (IRCE), said it is deepening research on Lassa fever vaccines and other viral threats as part of efforts to strengthen the country’s readiness for future outbreaks.
Speaking ahead of the institute’s 2025 Scientific Symposium in Abuja, IRCE executive director, Prof. Alash’le Abimiku, stressed that the symposium will focus on lessons from COVID-19 and Nigeria’s recurring struggles with epidemics such as cholera, diphtheria, and Lassa fever.
“Lassa virus remains problematic for Nigeria. We are currently working with partners on the potential testing of candidate vaccines, with the hope that in a few years, we can identify a vaccine that is effective against Lassa,” she said.
Prof. Abimiku added that IHVN’s goal is not only to develop vaccines and solutions but also to ensure that all research meets international standards.
Chief executive officer of IHVN, Dr. Patrick Dakum, explained that the research goes beyond vaccine trials to include understanding how viruses behave and spread.
He noted that the institute has studied variations in Lassa virus strains across different states as well as the habits of rodents that transmit the disease, to ensure vaccine development takes into account local peculiarities.
IHVN officials highlighted that the country’s participation in global studies, including those supported by the Coalition for Epidemic Preparedness Innovations (CEPI), has provided critical data for ongoing clinical trials across West Africa.
However, funding constraints remain a major challenge. Managing director and chief operating officer of IHVN, Dr. Charles Mensah, revealed that while progress is being made, research efforts have been slowed.
“Funding has substantially affected what we do. We are advocating to government at federal and state levels, and also reaching out to the private sector and donor agencies to support vaccine research and other critical studies,” he said.
Beyond Lassa fever, the symposium will feature discussions on Mpox, hepatitis, dengue fever, and other viral diseases. It will also explore how research can inform policies, strengthen Nigeria’s public health infrastructure, and boost the country’s preparedness for future pandemics.
The 2025 Scientific Symposium will bring together Nigerian and international researchers, government officials, and industry partners to discuss how to translate findings into policies and innovations that protect citizens from devastating viral diseases.
